Table of Content

1 Peptide Therapy Market Overview
1.1 Peptide Therapy Product Overview
1.2 Peptide Therapy Market Segment by Type
1.2.1 Parenteral Route of Administration
1.2.2 Mucosal Route of Administration
1.2.3 Oral Route of Administration
1.2.4 Transdermal Route of Administration
1.3 Global Peptide Therapy Market Size by Type
1.3.1 Global Peptide Therapy Market Size Overview by Type (2018-2029)
1.3.2 Global Peptide Therapy Historic Market Size Review by Type (2018-2024)
1.3.3 Global Peptide Therapy Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Peptide Therapy Sales Breakdown by Type (2018-2024)
1.4.2 Europe Peptide Therapy Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Peptide Therapy Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Peptide Therapy Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Peptide Therapy Sales Breakdown by Type (2018-2024)
2 Global Peptide Therapy Market Competition by Company
2.1 Global Top Players by Peptide Therapy Sales (2018-2024)
2.2 Global Top Players by Peptide Therapy Revenue (2018-2024)
2.3 Global Top Players by Peptide Therapy Price (2018-2024)
2.4 Global Top Manufacturers Peptide Therapy Manufacturing Base Distribution, Sales Area, Product Type
2.5 Peptide Therapy Market Competitive Situation and Trends
2.5.1 Peptide Therapy Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Peptide Therapy Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide Therapy as of 2022)
2.7 Date of Key Manufacturers Enter into Peptide Therapy Market
2.8 Key Manufacturers Peptide Therapy Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Peptide Therapy Status and Outlook by Region
3.1 Global Peptide Therapy Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Peptide Therapy Historic Market Size by Region
3.2.1 Global Peptide Therapy Sales in Volume by Region (2018-2024)
3.2.2 Global Peptide Therapy Sales in Value by Region (2018-2024)
3.2.3 Global Peptide Therapy Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Peptide Therapy Forecasted Market Size by Region
3.3.1 Global Peptide Therapy Sales in Volume by Region (2024-2029)
3.3.2 Global Peptide Therapy Sales in Value by Region (2024-2029)
3.3.3 Global Peptide Therapy Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Peptide Therapy by Application
4.1 Peptide Therapy Market Segment by Application
4.1.1 Cancer
4.1.2 Cardiovascular Diseases
4.1.3 Gastrointestinal Disorders
4.1.4 Metabolic Disorders
4.1.5 Others
4.2 Global Peptide Therapy Market Size by Application
4.2.1 Global Peptide Therapy Market Size Overview by Application (2018-2029)
4.2.2 Global Peptide Therapy Historic Market Size Review by Application (2018-2024)
4.2.3 Global Peptide Therapy Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Peptide Therapy Sales Breakdown by Application (2018-2024)
4.3.2 Europe Peptide Therapy Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Peptide Therapy Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Peptide Therapy Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Peptide Therapy Sales Breakdown by Application (2018-2024)
5 North America Peptide Therapy by Country
5.1 North America Peptide Therapy Historic Market Size by Country
5.1.1 North America Peptide Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Peptide Therapy Sales in Volume by Country (2018-2024)
5.1.3 North America Peptide Therapy Sales in Value by Country (2018-2024)
5.2 North America Peptide Therapy Forecasted Market Size by Country
5.2.1 North America Peptide Therapy Sales in Volume by Country (2024-2029)
5.2.2 North America Peptide Therapy Sales in Value by Country (2024-2029)
6 Europe Peptide Therapy by Country
6.1 Europe Peptide Therapy Historic Market Size by Country
6.1.1 Europe Peptide Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Peptide Therapy Sales in Volume by Country (2018-2024)
6.1.3 Europe Peptide Therapy Sales in Value by Country (2018-2024)
6.2 Europe Peptide Therapy Forecasted Market Size by Country
6.2.1 Europe Peptide Therapy Sales in Volume by Country (2024-2029)
6.2.2 Europe Peptide Therapy Sales in Value by Country (2024-2029)
7 Asia-Pacific Peptide Therapy by Region
7.1 Asia-Pacific Peptide Therapy Historic Market Size by Region
7.1.1 Asia-Pacific Peptide Therapy Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Peptide Therapy Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Peptide Therapy Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Peptide Therapy Forecasted Market Size by Region
7.2.1 Asia-Pacific Peptide Therapy Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Peptide Therapy Sales in Value by Region (2024-2029)
8 Latin America Peptide Therapy by Country
8.1 Latin America Peptide Therapy Historic Market Size by Country
8.1.1 Latin America Peptide Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Peptide Therapy Sales in Volume by Country (2018-2024)
8.1.3 Latin America Peptide Therapy Sales in Value by Country (2018-2024)
8.2 Latin America Peptide Therapy Forecasted Market Size by Country
8.2.1 Latin America Peptide Therapy Sales in Volume by Country (2024-2029)
8.2.2 Latin America Peptide Therapy Sales in Value by Country (2024-2029)
9 Middle East and Africa Peptide Therapy by Country
9.1 Middle East and Africa Peptide Therapy Historic Market Size by Country
9.1.1 Middle East and Africa Peptide Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Peptide Therapy Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Peptide Therapy Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Peptide Therapy Forecasted Market Size by Country
9.2.1 Middle East and Africa Peptide Therapy Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Peptide Therapy Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Information
10.1.2 Eli Lilly Introduction and Business Overview
10.1.3 Eli Lilly Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Eli Lilly Peptide Therapy Products Offered
10.1.5 Eli Lilly Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AstraZeneca Peptide Therapy Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck Peptide Therapy Products Offered
10.3.5 Merck Recent Development
10.4 Ipsen
10.4.1 Ipsen Company Information
10.4.2 Ipsen Introduction and Business Overview
10.4.3 Ipsen Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Ipsen Peptide Therapy Products Offered
10.4.5 Ipsen Recent Development
10.5 Novo Nordisk
10.5.1 Novo Nordisk Company Information
10.5.2 Novo Nordisk Introduction and Business Overview
10.5.3 Novo Nordisk Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novo Nordisk Peptide Therapy Products Offered
10.5.5 Novo Nordisk Recent Development
10.6 Teva Pharmaceutical Industries
10.6.1 Teva Pharmaceutical Industries Company Information
10.6.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.6.3 Teva Pharmaceutical Industries Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Teva Pharmaceutical Industries Peptide Therapy Products Offered
10.6.5 Teva Pharmaceutical Industries Recent Development
10.7 Abbott Laboratories
10.7.1 Abbott Laboratories Company Information
10.7.2 Abbott Laboratories Introduction and Business Overview
10.7.3 Abbott Laboratories Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Abbott Laboratories Peptide Therapy Products Offered
10.7.5 Abbott Laboratories Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sanofi Peptide Therapy Products Offered
10.8.5 Sanofi Recent Development
10.9 J & J
10.9.1 J & J Company Information
10.9.2 J & J Introduction and Business Overview
10.9.3 J & J Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.9.4 J & J Peptide Therapy Products Offered
10.9.5 J & J Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Introduction and Business Overview
10.10.3 Novartis Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Novartis Peptide Therapy Products Offered
10.10.5 Novartis Recent Development
10.11 Takeda
10.11.1 Takeda Company Information
10.11.2 Takeda Introduction and Business Overview
10.11.3 Takeda Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Takeda Peptide Therapy Products Offered
10.11.5 Takeda Recent Development
10.12 Ferring
10.12.1 Ferring Company Information
10.12.2 Ferring Introduction and Business Overview
10.12.3 Ferring Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Ferring Peptide Therapy Products Offered
10.12.5 Ferring Recent Development
10.13 AbbVie
10.13.1 AbbVie Company Information
10.13.2 AbbVie Introduction and Business Overview
10.13.3 AbbVie Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.13.4 AbbVie Peptide Therapy Products Offered
10.13.5 AbbVie Recent Development
10.14 Heinis
10.14.1 Heinis Company Information
10.14.2 Heinis Introduction and Business Overview
10.14.3 Heinis Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Heinis Peptide Therapy Products Offered
10.14.5 Heinis Recent Development
10.15 Hemmo
10.15.1 Hemmo Company Information
10.15.2 Hemmo Introduction and Business Overview
10.15.3 Hemmo Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Hemmo Peptide Therapy Products Offered
10.15.5 Hemmo Recent Development
10.16 Emcure Pharmaceutical
10.16.1 Emcure Pharmaceutical Company Information
10.16.2 Emcure Pharmaceutical Introduction and Business Overview
10.16.3 Emcure Pharmaceutical Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Emcure Pharmaceutical Peptide Therapy Products Offered
10.16.5 Emcure Pharmaceutical Recent Development
10.17 Cipla
10.17.1 Cipla Company Information
10.17.2 Cipla Introduction and Business Overview
10.17.3 Cipla Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Cipla Peptide Therapy Products Offered
10.17.5 Cipla Recent Development
10.18 Gland Pharma
10.18.1 Gland Pharma Company Information
10.18.2 Gland Pharma Introduction and Business Overview
10.18.3 Gland Pharma Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Gland Pharma Peptide Therapy Products Offered
10.18.5 Gland Pharma Recent Development
10.19 Troikaa Pharmaceuticals
10.19.1 Troikaa Pharmaceuticals Company Information
10.19.2 Troikaa Pharmaceuticals Introduction and Business Overview
10.19.3 Troikaa Pharmaceuticals Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Troikaa Pharmaceuticals Peptide Therapy Products Offered
10.19.5 Troikaa Pharmaceuticals Recent Development
10.20 Biological E
10.20.1 Biological E Company Information
10.20.2 Biological E Introduction and Business Overview
10.20.3 Biological E Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Biological E Peptide Therapy Products Offered
10.20.5 Biological E Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Peptide Therapy Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Peptide Therapy Industrial Chain Analysis
11.4 Peptide Therapy Market Dynamics
11.4.1 Peptide Therapy Industry Trends
11.4.2 Peptide Therapy Market Drivers
11.4.3 Peptide Therapy Market Challenges
11.4.4 Peptide Therapy Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Peptide Therapy Distributors
12.3 Peptide Therapy Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Parenteral Route of Administration
Table 2. Major Company of Mucosal Route of Administration
Table 3. Major Company of Oral Route of Administration
Table 4. Major Company of Transdermal Route of Administration
Table 5. Global Peptide Therapy Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Peptide Therapy Sales by Type (2018-2024) & (K Units)
Table 7. Global Peptide Therapy Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Peptide Therapy Sales by Type (2018-2024) & (US& Million)
Table 9. Global Peptide Therapy Market Share in Value by Type (2018-2024)
Table 10. Global Peptide Therapy Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Peptide Therapy Sales by Type (2024-2029) & (K Units)
Table 12. Global Peptide Therapy Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Peptide Therapy Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Peptide Therapy Sales Market Share in Value by Type (2024-2029)
Table 15. Global Peptide Therapy Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Peptide Therapy Sales by Type (2018-2024) & (K Units)
Table 17. North America Peptide Therapy Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Peptide Therapy Sales (K Units) by Type (2018-2024)
Table 19. Europe Peptide Therapy Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Peptide Therapy Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Peptide Therapy Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Peptide Therapy Sales (K Units) by Type (2018-2024)
Table 23. Latin America Peptide Therapy Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Peptide Therapy Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Peptide Therapy Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Peptide Therapy Sales by Company (2018-2024) & (K Units)
Table 27. Global Peptide Therapy Sales Share by Company (2018-2024)
Table 28. Global Peptide Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Peptide Therapy Revenue Share by Company (2018-2024)
Table 30. Global Market Peptide Therapy Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Peptide Therapy Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Peptide Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide Therapy as of 2022)
Table 34. Date of Key Manufacturers Enter into Peptide Therapy Market
Table 35. Key Manufacturers Peptide Therapy Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Peptide Therapy Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Peptide Therapy Sales by Region (2018-2024) & (K Units)
Table 39. Global Peptide Therapy Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Peptide Therapy Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Peptide Therapy Sales Market Share in Value by Region (2018-2024)
Table 42. Global Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Peptide Therapy Sales by Region (2024-2029) & (K Units)
Table 44. Global Peptide Therapy Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Peptide Therapy Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Peptide Therapy Sales Market Share in Value by Region (2024-2029)
Table 47. Global Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Peptide Therapy Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Peptide Therapy Sales by Application (2018-2024) & (K Units)
Table 50. Global Peptide Therapy Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Peptide Therapy Sales Market Share in Value by Application (2018-2024)
Table 53. Global Peptide Therapy Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Peptide Therapy Sales by Application (2024-2029) & (K Units)
Table 55. Global Peptide Therapy Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Peptide Therapy Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Peptide Therapy Sales Market Share in Value by Application (2024-2029)
Table 58. Global Peptide Therapy Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Peptide Therapy Sales by Application (2018-2024) (K Units)
Table 60. North America Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Peptide Therapy Sales by Application (2018-2024) (K Units)
Table 62. Europe Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Peptide Therapy Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Peptide Therapy Sales by Application (2018-2024) (K Units)
Table 66. Latin America Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Peptide Therapy Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 70. North America Peptide Therapy Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Peptide Therapy Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Peptide Therapy Sales Market Share in Value by Country (2018-2024)
Table 73. North America Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 74. North America Peptide Therapy Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Peptide Therapy Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Peptide Therapy Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 78. Europe Peptide Therapy Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Peptide Therapy Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Peptide Therapy Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 82. Europe Peptide Therapy Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Peptide Therapy Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Peptide Therapy Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Peptide Therapy Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Peptide Therapy Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Peptide Therapy Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Peptide Therapy Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Peptide Therapy Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Peptide Therapy Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Peptide Therapy Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Peptide Therapy Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Peptide Therapy Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Peptide Therapy Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Peptide Therapy Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Peptide Therapy Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Peptide Therapy Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Peptide Therapy Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Peptide Therapy Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Peptide Therapy Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Peptide Therapy Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Peptide Therapy Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Peptide Therapy Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Peptide Therapy Sales Market Share in Value by Country (2024-2029)
Table 109. Eli Lilly Company Information
Table 110. Eli Lilly Introduction and Business Overview
Table 111. Eli Lilly Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Eli Lilly Peptide Therapy Product
Table 113. Eli Lilly Recent Development
Table 114. AstraZeneca Company Information
Table 115. AstraZeneca Introduction and Business Overview
Table 116. AstraZeneca Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. AstraZeneca Peptide Therapy Product
Table 118. AstraZeneca Recent Development
Table 119. Merck Company Information
Table 120. Merck Introduction and Business Overview
Table 121. Merck Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Merck Peptide Therapy Product
Table 123. Merck Recent Development
Table 124. Ipsen Company Information
Table 125. Ipsen Introduction and Business Overview
Table 126. Ipsen Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Ipsen Peptide Therapy Product
Table 128. Ipsen Recent Development
Table 129. Novo Nordisk Company Information
Table 130. Novo Nordisk Introduction and Business Overview
Table 131. Novo Nordisk Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Novo Nordisk Peptide Therapy Product
Table 133. Novo Nordisk Recent Development
Table 134. Teva Pharmaceutical Industries Company Information
Table 135. Teva Pharmaceutical Industries Introduction and Business Overview
Table 136. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Teva Pharmaceutical Industries Peptide Therapy Product
Table 138. Teva Pharmaceutical Industries Recent Development
Table 139. Abbott Laboratories Company Information
Table 140. Abbott Laboratories Introduction and Business Overview
Table 141. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Abbott Laboratories Peptide Therapy Product
Table 143. Abbott Laboratories Recent Development
Table 144. Sanofi Company Information
Table 145. Sanofi Introduction and Business Overview
Table 146. Sanofi Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Sanofi Peptide Therapy Product
Table 148. Sanofi Recent Development
Table 149. J & J Company Information
Table 150. J & J Introduction and Business Overview
Table 151. J & J Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. J & J Peptide Therapy Product
Table 153. J & J Recent Development
Table 154. Novartis Company Information
Table 155. Novartis Introduction and Business Overview
Table 156. Novartis Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Novartis Peptide Therapy Product
Table 158. Novartis Recent Development
Table 159. Takeda Company Information
Table 160. Takeda Introduction and Business Overview
Table 161. Takeda Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Takeda Peptide Therapy Product
Table 163. Takeda Recent Development
Table 164. Ferring Company Information
Table 165. Ferring Introduction and Business Overview
Table 166. Ferring Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Ferring Peptide Therapy Product
Table 168. Ferring Recent Development
Table 169. AbbVie Company Information
Table 170. AbbVie Introduction and Business Overview
Table 171. AbbVie Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. AbbVie Peptide Therapy Product
Table 173. AbbVie Recent Development
Table 174. Heinis Company Information
Table 175. Heinis Introduction and Business Overview
Table 176. Heinis Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Heinis Peptide Therapy Product
Table 178. Heinis Recent Development
Table 179. Hemmo Company Information
Table 180. Hemmo Introduction and Business Overview
Table 181. Hemmo Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Hemmo Peptide Therapy Product
Table 183. Hemmo Recent Development
Table 184. Emcure Pharmaceutical Company Information
Table 185. Emcure Pharmaceutical Introduction and Business Overview
Table 186. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Emcure Pharmaceutical Peptide Therapy Product
Table 188. Emcure Pharmaceutical Recent Development
Table 189. Cipla Company Information
Table 190. Cipla Introduction and Business Overview
Table 191. Cipla Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 192. Cipla Peptide Therapy Product
Table 193. Cipla Recent Development
Table 194. Gland Pharma Company Information
Table 195. Gland Pharma Introduction and Business Overview
Table 196. Gland Pharma Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 197. Gland Pharma Peptide Therapy Product
Table 198. Gland Pharma Recent Development
Table 199. Troikaa Pharmaceuticals Company Information
Table 200. Troikaa Pharmaceuticals Introduction and Business Overview
Table 201. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 202. Troikaa Pharmaceuticals Peptide Therapy Product
Table 203. Troikaa Pharmaceuticals Recent Development
Table 204. Biological E Company Information
Table 205. Biological E Introduction and Business Overview
Table 206. Biological E Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 207. Biological E Peptide Therapy Product
Table 208. Biological E Recent Development
Table 209. Key Raw Materials Lists
Table 210. Raw Materials Key Suppliers Lists
Table 211. Peptide Therapy Market Trends
Table 212. Peptide Therapy Market Drivers
Table 213. Peptide Therapy Market Challenges
Table 214. Peptide Therapy Market Restraints
Table 215. Peptide Therapy Distributors List
Table 216. Peptide Therapy Downstream Customers
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Therapy Product Picture
Figure 2. Global Peptide Therapy Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Peptide Therapy Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Peptide Therapy Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Parenteral Route of Administration
Figure 6. Global Parenteral Route of Administration Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Mucosal Route of Administration
Figure 8. Global Mucosal Route of Administration Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Oral Route of Administration
Figure 10. Global Oral Route of Administration Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Transdermal Route of Administration
Figure 12. Global Transdermal Route of Administration Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Peptide Therapy Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Peptide Therapy Sales Market Share by Type in 2022 & 2029
Figure 15. North America Peptide Therapy Sales Market Share in Volume by Type in 2022
Figure 16. North America Peptide Therapy Sales Market Share in Value by Type in 2022
Figure 17. Europe Peptide Therapy Sales Market Share in Volume by Type in 2022
Figure 18. Europe Peptide Therapy Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Peptide Therapy Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Peptide Therapy Sales Market Share in Value by Type in 2022
Figure 21. Latin America Peptide Therapy Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Peptide Therapy Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Peptide Therapy Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Peptide Therapy Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Peptide Therapy Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Peptide Therapy Revenue in 2022
Figure 27. Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Cancer
Figure 29. Global Cancer Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Cardiovascular Diseases
Figure 31. Global Cardiovascular Diseases Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Gastrointestinal Disorders
Figure 33. Global Gastrointestinal Disorders Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Metabolic Disorders
Figure 35. Global Metabolic Disorders Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 38. Global Peptide Therapy Sales by Application (2018-2029) & (US$ Million)
Figure 39. Global Peptide Therapy Sales Market Share by Application in 2022 & 2029
Figure 40. North America Peptide Therapy Sales Market Share in Volume by Application in 2022
Figure 41. North America Peptide Therapy Sales Market Share in Value by Application in 2022
Figure 42. Europe Peptide Therapy Sales Market Share in Volume by Application in 2022
Figure 43. Europe Peptide Therapy Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Peptide Therapy Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Peptide Therapy Sales Market Share in Value by Application in 2022
Figure 46. Latin America Peptide Therapy Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Peptide Therapy Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Peptide Therapy Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Peptide Therapy Manufacturing Cost Structure
Figure 51. Peptide Therapy Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed